Supporting Independent Pharmacists Through COVID-19
The coronavirus pandemic has changed the world in significant ways, including how we do business and provide healthcare services to patients. Independent pharmacists are crucial for their communities and patients during COVID-19, providing health information, prescription services, and valuable resources.
At Rx30, we know there is a great concern for your community and patients, as well as worries about the health of your business. We are here to support you through this difficult time and ensure you have the tools and resources needed to run your business and serve your customers.
Transaction Data Systems, with our Rx30 solution, was the first pharmacy management software provider to transition to 100% remote work. All TDS employees are home safe and healthy, so we can better serve you during this time. Support hours have remained the same, and we are committed to providing strategic communication and updates, such as:
Weekly updates on the state of the business
Best practice information for COVID-19
Quick reference guides on solutions that are pertinent during the COVID-19 situation
Partner and payor/insurance updates as they arise, including payor delays, reimbursement changes, and credit processing information or rate locks
Our focus is on doing everything we can to make things easier for our clients. By simplifying anything we can during this hectic time and providing regular updates, we hope to ease the burden on our pharmacists and enable them to serve their communities.
Rx30 understands that flexible delivery options are key to serving your patients during this crisis. Using DeliveryRx provides your patients with a convenient option to obtain their prescriptions while following social distancing guideline and Shelter in Place orders. DeliveryRx works in many different configurations with the Rx30 system including POS 1.0, TDS POS and Rx30 PMS.
During this unprecedented time Rx30 is offering a no cost 90-day trail of the DeliveryRx app to Rx30 users who are currently not using the DeliveryRx app.
For more information, click here
Rx30 is committed to providing the latest information on COVID-19 that impacts independent pharmacists. We are constantly monitoring news outlets, health organizations, and reliable sources to provide the most up-to-date and accurate details on COVID-19.
New Guidelines Released for Pharmacy-Led COVID-19 Testing
- NCPDP released guidelines for pharmacies related to COVID-19 testing. Find the latest industry standards for administering tests here.
As of Wednesday, April 8, 2020, the U.S. Department of Health & Human Services authorized pharmacists to order administer COVID-19 tests. “Giving pharmacists the authorization to order and administer COVID-19 tests to their patients means easier access to testing for Americans who need it,” HHS Secretary Alex Azar said in a statement. Find more information on COVID-19 testing by pharmacists here.
- The DEA has released new guidance documents for pharmacies who have had their property impacted by civil unrest/looting. Learn more here.
Important Industry COVID-19 Links
- HHS Coronavirus Updates: The U.S. Department of Health and Human Services is leading the nation’s response to the COVID-19 pandemic.
- CDC Coronavirus Center: The Centers for Disease Control and Prevention organized a center for coronavirus updates for both patients and healthcare providers.
- CMS COVID-19 Partner Toolkit: The Centers for Medicare & Medicaid Services has provided a toolkit to help providers stay informed.
- NCPA COVID-19 Best Practices: Find updated community pharmacy best practices for COVID-19 response from NCPA.
- FDA COVID-19 Information: The FDA is working with the CDC and international partners to provide updates on COVID-19.
Here is a summary of recent Centers for Medicare & Medicaid Services (CMS) actions taken in response to the 2019 Novel Coronavirus (COVID-19), as part of the ongoing White House Task Force efforts. To keep up with the important work the Task Force is doing in response to COVID-19, click here www.coronavirus.gov. For information specific to CMS, please visit the CMS News Room and Current Emergencies Website. CMS updates these resources on an ongoing basis throughout the day; the information below is current as of April 16, 2020 at 10:15 a.m. ET.
CMS Increases Medicare Payment for High-Production Coronavirus Lab Tests
CMS announced that Medicare will nearly double payment for certain lab tests that use high-throughput technologies to rapidly diagnose large numbers of COVID-19 cases. This is another action the Trump Administration is taking to rapidly expand COVID-19 testing. Along with the March 30 announcement that Medicare will pay new specimen collection fees for COVID-19 testing, CMS’s actions will expand capability to test more vulnerable populations, like nursing home patients, quickly and provide results faster. Medicare will pay laboratories for the tests at $100 effective April 14, 2020, through the duration of the COVID-19 national emergency.
CMS Implements CARES Act Hospital Payment and Inpatient Rehabilitation Facility Waivers
The Coronavirus Aid, Relief, and Economic Security (CARES) Act increases payment for Inpatient Prospective Payment System (IPPS) and long-term care hospital (LTCH) inpatient hospital care attributable to COVID-19. CMS provided guidance for IPPS hospitals and LTCHs on how to code claims to receive the higher payment.
The CARES Act also waives the requirement that Medicare Part A fee-for-service patients treated in inpatient rehabilitation facilities receive at least 15 hours of therapy per week.
CMS Approves Additional State Medicaid Waivers and Amendments to Give States Flexibility to Address Coronavirus Pandemic
CMS has approved 52 COVID- related emergency waivers, 31 state amendments, 11 COVID-related Medicaid Disaster Amendments and one CHIP COVID-related Disaster Amendment in record time. States are using a toolkit CMS developed to expedite the application and approval of Medicaid state waivers and State Plan Amendments.
CMS recently approved two additional COVID-related emergency Medicaid waivers, delivering urgent regulatory relief to ensure the Commonwealth of Puerto Rico and the Commonwealth of the Northern Mariana Islands can quickly and effectively care for their most vulnerable citizens. CMS also approved COVID-related Medicaid Disaster Amendments that bring relief to Arkansas and Rhode Island. These approvals help to ensure that states have the tools they need to combat COVID-19 through a wide variety of state plan flexibilities. CMS continues to authorize amendments to ensure emergency flexibilities in programs that care for the elderly and people with disabilities, including most recently for Colorado, Louisiana and Nevada. These approved flexibilities support President Trump’s commitment to a COVID-19 response that is locally executed, state managed, and federally supported.